Diagnosis and treatment of psoriatic arthritis

Journal of the American Academy of Dermatology

Volumn 52, Issue 1, 2005, Pages 1-19

  Mease, Philip ^a   Goffe, Bernard S ^b  

^a Rheumatology Associates   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; ANTIPSORIASIS AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; CYTOKINE; DACLIZUMAB; EFALIZUMAB; ETANERCEPT; ETRETIN; ETRETINATE; HLA ANTIGEN; HYDROXYUREA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; INFLIXIMAB; KERATIN ANTIBODY; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

ANAMNESIS; ARTHROPATHY; ASTHMA; BACTERIAL INFECTION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYTOKINE PRODUCTION; DIAGNOSTIC PROCEDURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG APPROVAL; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; HEMATOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNOPATHOGENESIS; INFECTION COMPLICATION; INFECTIOUS ARTHRITIS; INFLAMMATORY INFILTRATE; JOINT DESTRUCTION; KIDNEY DISEASE; LIVER TOXICITY; LUNG TOXICITY; MENINGIOMA; META ANALYSIS; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; RADIODIAGNOSIS; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN IRRITATION; STRESS; T LYMPHOCYTE ACTIVATION; TENDON RUPTURE; TERATOGENICITY; TREATMENT INDICATION;

ARTHRITIS, PSORIATIC; HUMANS;

EID: 11144277873     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.06.013     Document Type: Review

References (146)

1. G. Krueger, J. Koo, and M. Lebwohl The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey Arch Dermatol 137 2001 280 284
2. Vital and health statistics: current estimates from the National Health Interview Survey, 1996 2003 Centers for Disease Control and Prevention, National Center for Health Statistics
3. National Psoriasis Foundation. About psoriasis Web page. Available at: http://www.psoriasis.org. Accessed November 12, 2003.
4. D.D. Gladman, and J. Brockbank Psoriatic arthritis Expert Opin Investig Drugs 9 2000 1511 1522
5. O. ElKayam, J. Ophir, M. Yaron, and D. Caspi Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution Clin Rheumatol 19 2000 301 305
6. D.D. Gladman Psoriatic arthritis Rheum Dis Clin North Am 24 1998 829 844
7. National Psoriasis Foundation. Benchmark survey on psoriasis and psoriatic arthritis. Available at: http://www.psoriasis.org/news/news/2001/ 200104_npfsurvey.php. Accessed August 9, 2003.
8. J.A. Husted, D.D. Gladman, V.T. Farewell, and R.J. Cook Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis Arthritis Rheum 45 2001 151 158
9. D. Buskila, P. Langevitz, D.D. Gladman, S. Urowitz, and H.A. Smythe Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis J Rheumatol 19 1992 1115 1119
10. D.D. Gladman, R. Shuckett, M.L. Russell, J.C. Thorne, and R.K. Schachter Psoriatic arthritis (PSA) - an analysis of 220 patients Q J Med 62 1987 127 141
11. P. Rahman, E. Nguyen, C. Cheung, C.T. Schentag, and D.D. Gladman Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis J Rheumatol 28 2001 1041 1044
12. K. Wong, D.D. Gladman, J. Husted, J.A. Long, and V.T. Farewell Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death Arthritis Rheum 40 1997 1868 1872
13. D.D. Gladman, V.T. Farewell, K. Wong, and J. Husted Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death Arthritis Rheum 41 1998 1103 1110
14. R.S. Stem Utilization of outpatient care for psoriasis J Am Acad Dermatol 35 1996 543 545
15. D. McGonagle, P.G. Conaghan, and P. Emery Psoriatic arthritis: a unified concept twenty years on Arthritis Rheum 42 1999 1080 1086
16. G.G. Krueger, S.R. Feldman, and C. Camisa Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 43 2000 281 285
17. A.B. Fleischer Jr., S.R. Feldman, and S.R. Rapp Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores J Invest Dermatol 107 1996 26 29
18. S.R. Rapp, S.R. Feldman, M.L. Exum, A.B. Fleischer Jr., and D.M. Reboussin Psoriasis causes as much disability as other major medical diseases J Am Acad Dermatol 41 1999 401 407
19. B. Kirby, H.L. Richards, and P. Woo Physical and psychologic measures are necessary to assess overall psoriasis severity J Am Acad Dermatol 45 2001 72 76
20. G.M. Kammer, N.A. Soter, D.J. Gibson, and P.H. Schur Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients Semin Arthritis Rheum 9 1979 75 97
21. K.E. McKenna, and R.S. Stern The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort J Am Acad Dermatol 36 1997 388 394
22. K.B. Sokoll, and P.S. Helliwell Comparison of disability and quality of life in rheumatoid and psoriatic arthritis J Rheumatol 28 2001 1842 1846
23. D.D. Gladman, E.N. Hing, C.T. Schentag, and R.J. Cook Remission in psoriatic arthritis J Rheumatol 28 2001 1045 1048
24. J.P. Ortonne Recent developments in the understanding of the pathogenesis of psoriasis Br J Dermatol 140 Suppl 54 1999 1 7
25. O. FitzGerald, and D. Kane Clinical, immunopathogenic, and therapeutic aspects of psoriatic arthritis Curr Opin Rheumatol 9 1997 295 301
26. J.M. Moll, and V. Wright Psoriatic arthritis Semin Arthritis Rheum 3 1973 55 78
27. M.J. Battistone, B.J. Manaster, D.J. Reda, and D.O. Clegg The prevalence of sacroiliitis in psoriatic arthritis: new perspectives from a large, multicenter cohort. A Department of Veterans Affairs Cooperative Study Skeletal Radiol 28 1999 196 201
28. P.S. Helliwell, P. Hickling, and V. Wright Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis 57 1998 135 140
29. R. Scarpa, P. Oriente, and A. Pucino The clinical spectrum of psoriatic spondylitis Br J Rheumatol 27 1988 133 137
30. J.C. Torre Alonso, P.A. Rodriguez, and J.M. Arribas Castrillo Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients Br J Rheumatol 30 1991 245 250
31. O.C. Biondi, R. Scarpa, A. Pucino, and P. Oriente Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report Acta Derm Venereol Suppl (Stockh) 146 1989 69 71
32. C. Pitzalis Skin and joint disease in psoriatic arthritis: what is the link? Br J Rheumatol 37 1998 480 483
33. W.A. Hammerschlag, J.R. Rice, D.S. Caldwell, and J.L. Goldner Psoriatic arthritis of the foot and ankle: analysis of joint involvement and diagnostic errors Foot Ankle 12 1991 35 39
34. M.R. Cohen, D.J. Reda, and D.O. Clegg Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies J Rheumatol 26 1999 1752 1756
35. H. Traupe The puzzling genetics of psoriasis Clin Dermatol 13 1995 99 103
36. J. Bhalerao, and A.M. Bowcock The genetics of psoriasis: a complex disorder of the skin and immune system Hum Mol Genet 7 1998 1537 1545
37. T. Hohler, and E. Marker-Hermann Psoriatic arthritis: clinical aspects, genetics, and the role of T cells Curr Opin Rheumatol 13 2001 273 279
38. T. Henseler The genetics of psoriasis J Am Acad Dermatol 37 1997 S1 S11
39. G. Swanbeck, A. Inerot, and T. Martinsson Genetic counselling in psoriasis: empirical data on psoriasis among first-degree relatives of 3095 psoriatic probands Br J Dermatol 137 1997 939 942
40. J.M. Moll, and V. Wright Familial occurrence of psoriatic arthritis Ann Rheum Dis 32 1973 181 201
41. L.R. Espinoza, R. van Solingen, M.L. Cuellar, and J. Angulo Insights into the pathogenesis of psoriasis and psoriatic arthritis Am J Med Sci 316 1998 271 276
42. D.D. Gladman, K.A. Anhorn, R.K. Schachter, and H. Mervart HLA antigens in psoriatic arthritis J Rheumatol 13 1986 586 592
43. N.J. McHugh, M.R. Laurent, B.L. Treadwell, J.M. Tweed, and J. Dagger Psoriatic arthritis: clinical subgroups and histocompatibility antigens Ann Rheum Dis 46 1987 184 188
44. D.D. Gladman, C. Cheung, C.M. Ng, and J.A. Wade HLA-C locus alleles in patients with psoriatic arthritis (PsA) Hum Immunol 60 1999 259 261
45. S. Gonzalez, J. Martinez-Borra, and J.C. Torre-Alonso The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw0602 in psoriasis Arthritis Rheum 42 1999 1010 1016
46. M. Rudwaleit, and T. Hohler Cytokine gene polymorphisms relevant for the spondyloarthropathies Curr Opin Rheumatol 13 2001 250 254
47. A.D. Burden, S. Javed, and M. Bailey Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p J Invest Dermatol 110 1998 958 960
48. L. Samuelsson, F. Enlund, and A. Torinsson A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach Hum Genet 105 1999 523 529
49. A.M. Bowcock Genetic locus for psoriasis identified Ann Med 27 1995 183 186
50. M.R. Laurent, G.S. Panayi, and P. Shepherd Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis Ann Rheum Dis 40 1981 66 69
51. O. Fyrand, O.J. Mellbye, and J.B. Natvig Immunofluorescence studies for immunoglobulins and complement C3 in synovial joint membranes in psoriatic arthritis Clin Exp Immunol 29 1977 422 427
52. R.P. Hall, L.H. Gerber, and T.J. Lawley IgA-containing immune complexes in patients with psoriatic arthritis Clin Exp Rheumatol 2 1984 221 225
53. J.N. Rosenberg, G.D. Johnson, and E.J. Holborow Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis Ann Rheum Dis 38 1979 526 528
54. P.G. Calzavara, R. Cattaneo, and F. Franceschini Antinuclear antibodies in psoriatic arthritis and its subgroups Acta Derm Venereol Suppl (Stockh) 146 1989 31 32
55. W.N. Jarjour, B.D. Jeffries, and J.S. Davis Autoantibodies to human stress proteins. A survey of various rheumatic and other inflammatory diseases Arthritis Rheum 34 1991 1133 1138
56. A.A. Borg, N.B. Nixon, P.T. Dawes, and D.L. Mattey Increased IgA antibodies to cytokeratins in the spondyloarthropathies Ann Rheum Dis 53 1994 391 395
57. A.A. Borg Antibodies to cytokeratins in inflammatory arthropathies Semin Arthritis Rheum 27 1997 186 195
58. P.G. Calzavara-Pinton, F. Franceschini, and C. Manera Antiperinuclear factor in psoriatic arthropathy J Am Acad Dermatol 40 1999 910 913
59. U. Fearon, and D.J. Veale Pathogenesis of psoriatic arthritis Clin Exp Dermatol 26 2001 333 337
60. J.D. Bos, and M.A. de Rie The pathogenesis of psoriasis: immunological facts and speculations Immunol Today 20 1999 40 46
61. S.L. Gottlieb, P. Gilleaudeau, and R. Johnson Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis Nat Med 1 1995 442 447
62. B.J. Nickoloff The immunologic and genetic basis of psoriasis Arch Dermatol 135 1999 1104 1110
63. P. Mease, A. Kivitz, and F. Burch Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): Results of a phase 3 multicenter clinical trial [abstract] Arthritis Rheum 44 Suppl 9 2001 S90 Abstract 226
64. H.J. Dinant, A.W. van Kuijk, A.Y. Goedkoop, MCdRMA Kraan, and B.A. Dijkmans Alefacept (LFA3-IgG1 fusion protein, LFA3TIP) reduces synovial inflammatory infiltrate and improves outcome in psoriatic arthritis [abstract] Arthritis Rheum 44 Suppl 2001 S91 Abstract 233
65. P. Strange, K.D. Cooper, and E.R. Hansen T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation J Invest Dermatol 101 1993 695 700
66. J.C. Prinz, B. Gross, and S. Vollmer T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products Eur J Immunol 24 1994 593 598
67. P. Costello, B. Bresnihan, C. O'Farrelly, and O. FitzGerald Predominance of CD8+ T lymphocytes in psoriatic arthritis J Rheumatol 26 1999 1117 1124
68. I. Tassiulas, S.R. Duncan, M. Centola, A.N. Theofilopoulos, and D.T. Boumpas Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis Hum Immunol 60 1999 479 491
69. P.J. Costello, R.J. Winchester, and S.A. Curran Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven J Immunol 166 2001 2878 2886
70. A. Mussi, C. Bonifati, and M. Carducci Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis J Biol Regul Homeost Agents 11 1997 115 118
71. G. Partsch, G. Steiner, and B.F. Leeb Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid J Rheumatol 24 1997 518 523
72. P.J. Mease, B.S. Goffe, and J. Metz Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial Lancet 356 2000 385 390
73. A.L. Ogilvie, C. Antoni, and C. Dechant Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate Br J Dermatol 144 2001 587 589
74. F.B. Vasey, C. Deitz, N.A. Fenske, B.F. Germain, and L.R. Espinoza Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis J Rheumatol 9 1982 719 722
75. M. Muto, Y. Date, and M. Ichimiya Significance of antibodies to streptococcal M protein in psoriatic arthritis and their association with HLA-A0207 Tissue Antigens 48 1996 645 650
76. Q. Wang, F.B. Vasey, and J.P. Mahfood V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis Arthritis Rheum 42 1999 2055 2059
77. M.U. Rahman, S. Ahmed, H.R. Schumacher, and A.R. Zeiger High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides J Rheumatol 17 1990 621 625
78. D.D. Gladman Psoriatic arthritis Curr Opin Rheumatol 2 1990 577 581
79. F.C. Arnett, J.D. Reveille, and M. Duvic Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection Rheum Dis Clin North Am 17 1991 59 78
80. L.R. Espinoza, L.J. Jara, and C.G. Espinoza There is an association between human immunodeficiency virus infection and spondyloarthropathies Rheum Dis Clin North Am 18 1992 257 266
81. P. Njobvu, and P. McGill Psoriatic arthritis and human immunodeficiency virus infection in Zambia J Rheumatol 27 2000 1699 1702
82. L. Brancato, S. Itescu, M.L. Skovron, G. Solomon, and R. Winchester Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter's syndrome and related disorders associated with HIV infection Rheumatol Int 9 1989 137 141
83. R. Winchester, L. Brancato, S. Itescu, M.L. Skovron, and G. Solomon Implications from the occurrence of Reiter's syndrome and related disorders in association with advanced HIV infection Scand J Rheumatol Suppl 74 1988 89 93
84. D.D. Gladman Clinical aspects of the spondyloarthropathies Am J Med Sci 316 1998 234 238
85. W.F. Barth Office evaluation of the patient with musculoskeletal complaints Am J Med 102 1997 3S 10S
86. C.J. Michet Psoriatic arthritis W.N. Kelley E.D. Harris S. Ruddy C.B. Sledge Textbook of rheumatology 1993 WB Saunders Philadelphia 974 984
87. R.M. Bennet Psoriatic arthritis W.J. Koopman Arthritis and allied conditions: a textbook of rheumatology 2001 William & Wilkins Philadelphia 1345 1361
88. G.C. Gardner, and N.J. Kadel Ordering and interpreting rheumatologic laboratory tests J Am Acad Orthop Surg 11 2003 60 67
89. D.J. Kane, T. Saxne, J.P. Doran, B. Bresnihan, and O. FitzGerald A comparison of the ESR, CRP, serum amyloid A and cartilage oligomeric matrix protein in assessing inflammation and predicting radiological outcome in early psoriatic arthritis [abstract] Arthritis Rheum 48 Suppl 9 2003 S178 Abstract 367
90. J.G. Hanly, M.L. Russell, and D.D. Gladman Psoriatic spondyloarthropathy: a long term prospective study Ann Rheum Dis 47 1988 386 393
91. R. Scarpa, and A. Mathieu Psoriatic arthritis: evolving concepts Curr Opin Rheumatol 12 2000 274 280
92. C. Salvarani, I. Olivieri, F. Cantini, L. Macchioni, and L. Boiardi Psoriatic arthritis Curr Opin Rheumatol 10 1998 299 305
93. K.J. Stevens, S.L. Smith, B.J. Preston, and C. Deighton Tumoral enthesopathy in psoriasis Rheumatology (Oxford) 40 2001 342 344
94. S. Marsal, L. Armadans-Gil, and M. Martinez Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis Rheumatology (Oxford) 38 1999 332 337
95. B. Fournié, L. Crognier, and C. Arnaud Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients Rev Rhum Engl Ed 66 1999 446 456
96. D.D. Gladman, V.T. Farewell, K.A. Kopciuk, and R.J. Cook HLA markers and progression in psoriatic arthritis J Rheumatol 25 1998 730 733
97. P.M. Witman Topical therapies for localized psoriasis Mayo Clin Proc 76 2001 943 949
98. C. Camisa Psoriasis: a clinical update on diagnosis and new therapies Cleve Clin J Med 67 2000 105 113 117
99. D.D. Gladman, and V.T. Farewell Progression in psoriatic arthritis: role of time varying clinical indicators J Rheumatol 26 1999 2409 2413
100. G. Jones, M. Crotty, and P. Brooks Interventions for psoriatic arthritis Cochrane Database Syst Rev 2000 CD000212
101. D. Lacaille, H.B. Stein, J. Raboud, and A.V. Klinkhoff Longterm therapy of psoriatic arthritis: intramuscular gold or methotrexate? J Rheumatol 27 2000 1922 1927
102. M. Abu-Shakra, D.D. Gladman, and J.C. Thorne Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome J Rheumatol 22 1995 241 245
103. C.A. Phillips, P.J. Cera, T.F. Mangan, and E.D. Newman Clinical liver disease in patients with rheumatoid arthritis taking methotrexate J Rheumatol 19 1992 229 233
104. H.H. Roenigk Jr., R. Auerbach, H. Maibach, G. Weinstein, and M. Lebwohl Methotrexate in psoriasis: consensus conference J Am Acad Dermatol 38 1998 478 485
105. I. Olivieri, C. Salvarani, and F. Cantini Therapy with cyclosporine in psoriatic arthritis Semin Arthritis Rheum 27 1997 36 43
106. A. Spadaro, E. Taccari, and B. Mohtadi Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs Clin Exp Rheumatol 15 1997 609 614
107. P. Rahman, D.D. Gladman, R.J. Cook, Y. Zhou, and G. Young The use of sulfasalazine in psoriatic arthritis: a clinic experience J Rheumatol 25 1998 1957 1961
108. A.D. Fraser, A. van Kuryk, and R. Westhovens A randomised, double-blind, placebo controlled multi-centre trial of combination therapy with methotrexate plus cyclosporin vs methotrexate plus placebo in patients with active psoriatic arthritis (PsA) [abstract] Arthritis Rheum 48 Suppl 9 2003 S170 Abstract 344
109. J.P. Kaltwasser, P. Nash, D. Gladman, C.F. Rosen, F. Behrens, and P. Jones Treatment of Psoriatic Arthritis Study Group Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial Arthritis Rheum 50 2004 1939 1950
110. A.E. Koch, S.L. Kunkel, and R.M. Strieter Cytokines in rheumatoid arthritis J Investig Med 43 1995 28 38
111. P. Ettehadi, M.W. Greaves, D. Wallach, D. Aderka, and R.D. Camp Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions Clin Exp Immunol 96 1994 146 151
112. S. Terajima, M. Higaki, Y. Igarashi, T. Nogita, and M. Kawashima An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis Arch Dermatol Res 290 1998 246 252
113. C. Ritchlin, S.A. Haas-Smith, and D. Hicks Patterns of cytokine production in psoriatic synovium J Rheumatol 25 1998 1544 1552
114. C. Tetta, G. Camussi, V. Modena, C. Di Vittorio, and C. Baglioni Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis Ann Rheum Dis 49 1990 665 667
115. G. Husby, and R.C. Williams Jr. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis J Autoimmun 1 1988 363 371
116. W.O. Cooper, R.A. Fava, C.A. Gates, M.A. Cremer, and A.S. Townes Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta Clin Exp Immunol 89 1992 244 250
117. J. Keffer, L. Probert, and H. Cazlaris Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis EMBO J 10 1991 4025 4031
118. R.O. Williams, M. Feldmann, and R.N. Maini Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci U S A 89 1992 9784 9788
119. Enbrel® (etanercept) [package insert] 2004 Amgen Inc. and Wyeth Pharmaceuticals Thousand Oaks (CA)
120. P. Mease, E. Siegel, E.M. Ruderman, A. Kivitz, F. Burch, and S.B. Cohen Etanercept (Enbrel) in patients with psoriatic arthritis and psoriasis: continued observations [abstract] Ann Rheum Dis 62 Suppl 1 2003
121. ®) inhibits radiographic progression in patients with psoriatic arthritis [abstract] Arthritis Rheum 46 Suppl 2002 S196 Abstract 442
122. L.A. Wanke, A.B. Gottlieb, and P.J. Mease Etanercept (ENBREL) improves health-related quality of life in patients with psoriatic arthritis [abstract] Arthritis Rheum 46 Suppl 2002 Abstract 97
123. P.J. Mease, A.J. Kivitz, F.X. Burch, E.L. Siegel, S.B. Cohen, and P. Ory Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression Arthritis Rheum 50 2004 2264 2272
124. P.J. Mease, A.J. Kivitz, and F. Burch Etanercept (ENBREL) inhibits radiographic progression in patients with psoriatic arthritis [abstract] Arthritis Rheum 46 Suppl 2002 S196 Abstract 442
125. P. Ory, J.T. Sharp, D. Salonen, J.D. Rubenstein, P.J. Mease, and E.M. Ruderman Etanercept (Enbrel) inhibits radiographic progression in patients with psoriatic arthritis [abstract] Ann Rheum Dis 62 Suppl 1 2003 Abstract OP0089
126. Ritchlin CT, Haas-Smith SA, Shao T, Durham R, Monu J, Suk Seo G, et al. Etanercept lowers the frequency of circulating osteoclast precursors (OCP) and improves bone marrow edema in patients with erosive psoriatic arthritis [abstract]. Presented at: 67th Annual Scientific Meeting of the American College of Rheumatology; October 23-28, 2003; Orlando (FL).
127. B. Bruce, and J.F. Fries The Stanford Health Assessment Questionnaire: dimensions and practical applications Health Qual Life Outcomes 1 2003 20
128. P.J. Mease, A.B. Gottlieb, L.A. Wanke, and D.J. Burge Sustained improvement in activities of daily living in patients with psoriatic arthritis treated with etanercept [abstract] Arthritis Rheum 48 Suppl 9 2003 S167 Abstract 336
129. R.W. Martin, and L.A. Wanke Etanercept plus a patient education and support system improve health-related quality of life in rheumatoid arthritis patients in a clinical practice setting [abstract] Arthritis Rheum 48 Suppl 9 2003 S424 Abstract 1056
130. C.L. Leonardi, J.L. Powers, and R.T. Matheson Etanercept as monotherapy in patients with psoriasis N Engl J Med 349 2003 2014 2022
131. L. Mellemkjaer, M.S. Linet, and G. Gridley Rheumatoid arthritis and cancer risk Eur J Cancer 32A 1996 1753 1757
132. E. Baecklund, A. Ekbom, P. Sparen, N. Feltelius, and L. Klareskog Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study BMJ 317 1998 180 181
133. Antoni C, Smolen J, The IMPACT Study Group. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). Poster presented at: 61st Annual Meeting of the American Academy of Dermatology; March 21-26, 2003; San Francisco. Poster 9.
134. C. Antoni, and B. Manger Infliximab for psoriasis and psoriatic arthritis Clin Exp Rheumatol 20 2002 S122 S125
135. C. Antoni, C. Dechant, and P.D. Hanns-Martin Lorenz Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation Arthritis Rheum 47 2002 506 512
136. C. Antoni, A. Kavanaugh, B. Kirkham, G.R. Burmeister, M. Weisman, and E. Keystone The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [abstract] Arthritis Rheum 47 Suppl 9 2003 S381
137. C. Antoni, A. Kavanaugh, and B. Kirkham The one year results of the infliximab multinational psoriatic arthritis controlled trial (IMPACT) [abstract] Arthritis Rheum 47 Suppl 9 2003 S265 Abstract 604
138. J.M. Kremer Rational use of new and existing disease-modifying agents in rheumatoid arthritis Ann Intern Med 134 2001 695 706
139. R.N. Maini, F.C. Breedveld, and J.R. Kalden Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1998 1552 1563
140. Remicade [package insert] 2002 Centocor, Inc Malvern (PA)
141. C.N. Ellis, and G.G. Krueger Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes N Engl J Med 345 2001 248 255
142. C. Robert, and T.S. Kupper Inflammatory skin diseases, T cells, and immune surveillance N Engl J Med 341 1999 1817 1828
143. FaxWatch [press release]. Genentech, Xoma's Raptiva fails to meet endpoint in Phase II psoriatic arthritis trial. March 22, 2004.
144. J.G. Krueger, I.B. Walters, and M. Miyazawa Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis J Am Acad Dermatol 43 2000 448 458
145. R.C. Mehta, K.K. Stecker, and S.R. Cooper Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides J Invest Dermatol 115 2000 805 812
146. S. Iyer, P. Yamauchi, and N.J. Lowe Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy Br J Dermatol 146 2002 118 121